DK1480622T3 - Farmaceutiske, granulære immediate release-præparater og en kontinuert fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutiske, granulære immediate release-præparater og en kontinuert fremgangsmåde til fremstilling deraf

Info

Publication number
DK1480622T3
DK1480622T3 DK03743276T DK03743276T DK1480622T3 DK 1480622 T3 DK1480622 T3 DK 1480622T3 DK 03743276 T DK03743276 T DK 03743276T DK 03743276 T DK03743276 T DK 03743276T DK 1480622 T3 DK1480622 T3 DK 1480622T3
Authority
DK
Denmark
Prior art keywords
preparation
continuous process
immediate release
release preparations
pharmaceutical granular
Prior art date
Application number
DK03743276T
Other languages
Danish (da)
English (en)
Inventor
Kris Vervaet
Jean-Paul Remon
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of DK1480622T3 publication Critical patent/DK1480622T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03743276T 2002-03-06 2003-03-05 Farmaceutiske, granulære immediate release-præparater og en kontinuert fremgangsmåde til fremstilling deraf DK1480622T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205253.8A GB0205253D0 (en) 2002-03-06 2002-03-06 Immediate release pharmaceutical granule compositions and a continuous process for making them
PCT/BE2003/000040 WO2003074031A1 (en) 2002-03-06 2003-03-05 Immediate release pharmaceutical granule compositions and a continuous process for making them

Publications (1)

Publication Number Publication Date
DK1480622T3 true DK1480622T3 (da) 2009-02-16

Family

ID=9932403

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03743276T DK1480622T3 (da) 2002-03-06 2003-03-05 Farmaceutiske, granulære immediate release-præparater og en kontinuert fremgangsmåde til fremstilling deraf

Country Status (22)

Country Link
US (4) US20050058705A1 (de)
EP (1) EP1480622B1 (de)
KR (1) KR20040091099A (de)
CN (1) CN1638738B (de)
AR (1) AR038880A1 (de)
AT (1) ATE418327T1 (de)
AU (1) AU2003215449B2 (de)
BR (1) BR0308231A (de)
CA (1) CA2477890C (de)
DE (1) DE60325461D1 (de)
DK (1) DK1480622T3 (de)
ES (1) ES2318147T3 (de)
GB (1) GB0205253D0 (de)
HK (1) HK1078006A1 (de)
MX (1) MXPA04008543A (de)
MY (1) MY138752A (de)
PL (1) PL208133B1 (de)
PT (1) PT1480622E (de)
SA (1) SA03240089B1 (de)
TW (1) TWI296198B (de)
WO (1) WO2003074031A1 (de)
ZA (1) ZA200407998B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205253D0 (en) 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
EP1620075B1 (de) * 2003-05-07 2020-06-24 Samyang Biopharmaceuticals Corporation Hochplastische granulate zur herstellung von schnell schmelzenden tabletten
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US7888412B2 (en) 2004-03-26 2011-02-15 Board Of Trustees Of The University Of Alabama Polymer dissolution and blend formation in ionic liquids
US7550520B2 (en) 2005-05-31 2009-06-23 The University Of Alabama Method of preparing high orientation nanoparticle-containing sheets or films using ionic liquids, and the sheets or films produced thereby
US8883193B2 (en) 2005-06-29 2014-11-11 The University Of Alabama Cellulosic biocomposites as molecular scaffolds for nano-architectures
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
CA2660086C (en) * 2006-08-16 2014-09-16 Novartis Ag Method of making solid dispersions of highly crystalline therapeutic compounds
WO2008021666A2 (en) * 2006-08-18 2008-02-21 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
MX2009006714A (es) * 2006-12-19 2009-08-31 Schering Plough Ltd Formulaciones efervescentes de florfenicol para adicion en sistemas de agua potable.
PE20090234A1 (es) * 2007-04-27 2009-04-02 Schering Plough Ltd Composiciones farmaceuticas que comprenden florfenicol y ciclodextrinas
US8668807B2 (en) 2008-02-19 2014-03-11 Board Of Trustees Of The University Of Alabama Ionic liquid systems for the processing of biomass, their components and/or derivatives, and mixtures thereof
EP2282973A2 (de) * 2008-04-28 2011-02-16 Formac Pharmaceuticals N.v. Geordnetes mesoporöses siliciumdioxidmaterial
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
WO2010078300A1 (en) 2008-12-29 2010-07-08 The Board Of Trustees Of The University Of Alabama Dual functioning ionic liquids and salts thereof
WO2010141470A2 (en) 2009-06-01 2010-12-09 The Board Of Trustees Of The University Of Alabama Process for forming films, fibers, and beads from chitinous biomass
WO2011011322A1 (en) 2009-07-24 2011-01-27 The Board Of Trustees Of The University Of Alabama Conductive composites prepared using ionic liquids
BRPI1002023A2 (pt) * 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CN101843586B (zh) * 2010-04-29 2012-05-23 山东迅达康兽药有限公司 一种含有氟苯尼考的可溶于水的微粉及其制备方法
CN102178068B (zh) * 2010-07-06 2013-07-31 新疆农业大学 一种饲料添加剂的使用方法
US9394375B2 (en) 2011-03-25 2016-07-19 Board Of Trustees Of The University Of Alabama Compositions containing recyclable ionic liquids for use in biomass processing
EP2704694A4 (de) * 2011-05-02 2014-11-19 Aptalis Pharmatech Inc Schnell auflösende tablettenzusammensetzungen zur vaginalen verabreichung
EP2537518A1 (de) * 2011-06-24 2012-12-26 Elanco Animal Health Ireland Limited Schnell zerfallendene Azaperon-Granulatformulierungen
RU2015132902A (ru) 2013-01-07 2017-02-09 Сам-А Фарм. Ко., Лтд. Новый быстрорастворимый состав гранул с улучшенной растворимостью
BR102013020508B1 (pt) * 2013-08-12 2021-01-12 Ems S/A. Forma de dosagem que compreende um inibidor de esteroide 5-alfa-redutase e um bloqueador alfa, processo para a preparaçãode uma forma de dosagem e uso da forma de dosagem
US10100131B2 (en) 2014-08-27 2018-10-16 The Board Of Trustees Of The University Of Alabama Chemical pulping of chitinous biomass for chitin
US10982381B2 (en) 2014-10-06 2021-04-20 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing welded substrates
US10011931B2 (en) 2014-10-06 2018-07-03 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing dyed and welded substrates
ES2948806T3 (es) 2015-02-17 2023-09-19 Univ Gent Forma de dosificación farmacéutica sólida adecuada para su uso como medicación en agua potable
EP3423063A4 (de) * 2016-03-04 2019-11-06 Embera Neurotherapeutics, Inc Zusammensetzungen und verfahren zur behandlung von sucht oder substanzmissbrauchsstörungen
US11766835B2 (en) 2016-03-25 2023-09-26 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing welded substrates
KR102304833B1 (ko) 2016-05-03 2021-09-24 네추럴 파이버 웰딩 인코포레이티드 염색되고 용접된 기재를 제조하기 위한 방법, 공정, 및 장치
CN108210501B (zh) * 2016-12-14 2019-03-08 中国人民解放军军事医学科学院毒物药物研究所 一种磺酰脲类药物的注射用药物组合物及其制备方法
US10927191B2 (en) 2017-01-06 2021-02-23 The Board Of Trustees Of The University Of Alabama Coagulation of chitin from ionic liquid solutions using kosmotropic salts
EP3592350A4 (de) 2017-03-10 2020-12-23 Embera NeuroTherapeutics, Inc. Pharmazeutische zusammensetzungen und verwendungen davon
WO2018236445A2 (en) 2017-03-24 2018-12-27 The Board Of Trustees Of The University Of Alabama METALLIC-CHITIN PARTICLE COMPOSITE MATERIALS AND METHODS OF MAKING SAME
JP7532341B2 (ja) * 2018-09-06 2024-08-13 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド 注射可能な徐放性の抗生物質製剤
CN114532451B (zh) * 2022-02-28 2023-06-02 安徽科技学院 一种促进肉羊育肥的中药组方添加剂及制备方法
CN116019771A (zh) * 2022-09-09 2023-04-28 沈阳伟嘉生物技术有限公司 一种氟苯尼考可混饮无定形固体分散体制剂及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639637A (en) * 1968-04-23 1972-02-01 Richardson Merrell Inc Water dispersible diethylstilbestrol compositions
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
IT1182857B (it) * 1984-09-14 1987-10-05 Glaxo Group Ltd Composti antibiotici, composizioni antiparassitarie che li contengono e procedimento per prepararli ed applicarli
DE3440288C2 (de) 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
IT1187751B (it) 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
FR2634376B1 (fr) 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
GB8913889D0 (en) 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
IT1246188B (it) 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
DE69222182T2 (de) * 1991-12-18 1998-02-26 Warner Lambert Co Verfahren für die herstellung einer festen dispersion
US5362860A (en) * 1993-02-01 1994-11-08 Warner-Lambert Company Neutral stabilization complex for CI-979 HCl, a cognition activator
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
HN1998000115A (es) * 1997-08-21 1999-06-02 Warner Lambert Co Formas de dosificación farmacéuticas sólidas
US6153206A (en) * 1997-08-27 2000-11-28 Revlon Consumer Products Corporation Cosmetic compositions
EA002806B1 (ru) 1997-09-11 2002-10-31 Нюкомед Данмарк А/С Многоединичные композиции с модифицированным высвобождением нестероидных противовоспалительных лекарственных веществ (nsaid)
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
US6211185B1 (en) * 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent
US20010046526A1 (en) * 2000-04-19 2001-11-29 C-Quest Treatment of fungal infections
JP5162071B2 (ja) * 2000-05-03 2013-03-13 ドシルバ，ジヨー 液体投与調合物を製造する方法および装置
WO2002017877A2 (en) * 2000-08-31 2002-03-07 Universiteit Gent Controlled release pharmaceutical pellet compositions for reducing side effects of drugs
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
KR20040079967A (ko) * 2002-02-01 2004-09-16 화이자 프로덕츠 인크. 고체 약물 분산액을 함유하는 속방형 제형
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them

Also Published As

Publication number Publication date
ES2318147T3 (es) 2009-05-01
US20050058705A1 (en) 2005-03-17
TW200305446A (en) 2003-11-01
AU2003215449A1 (en) 2003-09-16
EP1480622A1 (de) 2004-12-01
US20110027377A1 (en) 2011-02-03
TWI296198B (en) 2008-05-01
AU2003215449B2 (en) 2007-07-26
KR20040091099A (ko) 2004-10-27
CA2477890C (en) 2011-05-10
US20110008454A1 (en) 2011-01-13
GB0205253D0 (en) 2002-04-17
SA03240089B1 (ar) 2008-07-12
PL372579A1 (en) 2005-07-25
PT1480622E (pt) 2009-03-06
CN1638738A (zh) 2005-07-13
MXPA04008543A (es) 2004-12-06
CN1638738B (zh) 2012-06-06
CA2477890A1 (en) 2003-09-12
US20070009592A1 (en) 2007-01-11
ZA200407998B (en) 2006-06-28
ATE418327T1 (de) 2009-01-15
US8337897B2 (en) 2012-12-25
WO2003074031A1 (en) 2003-09-12
HK1078006A1 (en) 2006-03-03
BR0308231A (pt) 2004-12-28
EP1480622B1 (de) 2008-12-24
AR038880A1 (es) 2005-02-02
US8349366B2 (en) 2013-01-08
PL208133B1 (pl) 2011-03-31
MY138752A (en) 2009-07-31
DE60325461D1 (de) 2009-02-05

Similar Documents

Publication Publication Date Title
DK1480622T3 (da) Farmaceutiske, granulære immediate release-præparater og en kontinuert fremgangsmåde til fremstilling deraf
DK1562573T3 (da) Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf
DK1534237T3 (da) Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf
NO20014013L (no) 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
TWI347201B (en) Pharmaceutical products,uses thereof and methods for preparing the same
PL400027A1 (pl) Wieloelementowa farmaceutyczna postac dawkowania i sposób jej wytwarzania
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
GB0214013D0 (en) Pharmaceutical product
EP1601345A4 (de) System mit kontrollierter freisetzung für pharmazeutische nahrungsmittel und nutrazeutische verwendung
NO20052285D0 (no) Faste, partikkelformige, antifungale preparater for farmasoytisk anvendelse
DK1294682T3 (da) Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK1381605T3 (da) Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
PL377656A1 (pl) Ligandy Ó2Ű do różnych zastosowań farmaceutycznych
DK1144386T3 (da) Polymorf form af telmisartan, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel
TWI319318B (en) Modified release pharmaceutical formulation
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
DK1560826T3 (da) Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
PL374528A1 (en) New effector conjugates, process for their production and their pharmaceutical use
NO20013900L (no) Epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
NO20043333L (no) Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem
DK1608811T3 (da) Flerlagsprodukt og fremgangsmåde til fremstillingen deraf
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
DK1411057T3 (da) [3,,4.a:3,4-c]carbazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse